清家正博 (Masahiro Seike) - 論文

Namiko Taniuchi, Yoshinobu Saito, Norio Motoda, Masahiro Seike

Journal of Nippon Medical School = Nippon Ika Daigaku zasshi 2024年1月16日査読有り

Clinicopathological characteristics of everolimus-associated interstitial lung disease: A single-center consecutive analysis.

Yoshinobu Saito, Yasuhiro Terasaki, Takeru Kashiwada, Toru Tanaka, Hiroyuki Takei, Go Kimura, Yukihiro Kondo, Tetsuro Kawagoe, Akira Matsushita, Rintaro Noro …

Journal of Nippon Medical School = Nippon Ika Daigaku zasshi 2024年1月16日査読有り

A phase II study of atezolizumab with bevacizumab, carboplatin, and paclitaxel for patients with EGFR-mutated NSCLC after TKI treatment failure (NEJ043 study).

Satoshi Watanabe, Naoki Furuya, Atsushi Nakamura, Jun Shiihara, Ichiro Nakachi, Hisashi Tanaka, Mika Nakao, Koichi Minato, Masahiro Seike, Shinichi Sasaki …

European journal of cancer (Oxford, England : 1990) 197 113469-113469 2023年12月2日査読有り

多発脳梗塞を併発し急速な経過で死亡した劇症型G群溶連菌感染症の1例

角田寛太, 谷内七三子, 許田典男, 佐藤純平, 山口玲, 齊藤翔, 青山純一, 西島伸彦, 清家正博, 齋藤好信

日本内科学会関東地方会 692回 29-29 2023年12月

Prognostic significance of initial tumor shrinkage in patients with stage III non-small cell lung cancer treated with durvalumab following chemoradiotherapy.

Yuto Terashima, Taiki Hakozaki, Yuji Uehara, Akihiko Miyanaga, Kazuo Kasahara, Masahiro Seike, Yukio Hosomi

International journal of clinical oncology 2023年11月30日招待有り

Predictive Impact of Diffuse Positivity for TTF-1 Expression in Patients Treated With Platinum-Doublet Chemotherapy Plus Immune Checkpoint Inhibitors for Advanced Nonsquamous NSCLC.

Yuto Terashima, Masaru Matsumoto, Hiroki Iida, Sae Takashima, Aya Fukuizumi, Susumu Takeuchi, Akihiko Miyanaga, Yasuhiro Terasaki, Kazuo Kasahara, Masahiro Seike

JTO clinical and research reports 4(11) 100578-100578 2023年11月査読有り責任著者

A highly specific antibody against the core fucose of the N-glycan in IgG identifies the pulmonary diseases and its regulation by CCL2.

Noriko Kanto, Yuki Ohkawa, Masato Kitano, Kento Maeda, Masafumi Shiida, Tatsuya Ono, Fumi Ota, Yasuhiko Kizuka, Kei Kunimasa, Kazumi Nishino …

The Journal of biological chemistry 299(12) 105365-105365 2023年10月20日査読有り

Influence of background cardiovascular risk factors on VEGF inhibitor-related adverse vascular events in patients with non-small cell lung cancer: a retrospective study.

Tomoyuki Naito, Yuji Minegishi, Hideaki Shiraishi, Tatsuhiko Hoshino, Junichi Maeda, Toshiya Yokota, Shingo Ikeda, Miyanaga Akihiko, Masahiro Seike

Journal of cancer research and clinical oncology 149(13) 12435-12442 2023年10月査読有り

Thyroid transcription factor-1 (TTF-1) expression and the efficacy of combination therapy with immune checkpoint inhibitors and cytotoxic chemotherapy in non-squamous non-small cell lung cancer.

Hirokazu Iso, Kakeru Hisakane, Erika Mikami, Takahiro Suzuki, Satoru Matsuki, Kenichiro Atsumi, Kohji Nagata, Masahiro Seike, Takashi Hirose

Translational lung cancer research 12(9) 1850-1861 2023年9月28日査読有り

Osimertinib early dose reduction as a risk to brain metastasis control in EGFR-mutant non-small cell lung cancer.

Takehiro Tozuka, Rintaro Noro, Akihiko Miyanaga, Shinji Nakamichi, Susumu Takeuchi, Masaru Matsumoto, Kaoru Kubota, Kazuo Kasahara, Masahiro Seike

Cancer medicine 12(17) 17731-17739 2023年9月11日査読有り責任著者

Increased CTGF expression in alveolar epithelial cells by cyclic mechanical stretch: Its mechanism and the therapeutic effect of pirfenidone.

Junichi Aoyama, Yoshinobu Saito, Kuniko Matsuda, Toru Tanaka, Koichiro Kamio, Akihiko Gemma, Masahiro Seike

Respiratory physiology & neurobiology 317 104142-104142 2023年8月23日査読有り

Minimal effective dose of maintenance steroid therapy for relapse of cryptogenic organizing pneumonia.

Kenichiro Atsumi, Kakeru Hisakane, Erika Mikami, Takahiro Suzuki, Satoru Matsuki, Masahiro Seike, Takashi Hirose

Respiratory medicine 107390-107390 2023年8月19日査読有り

A remarkable response to combination chemotherapy with nivolumab and ipilimumab in a patient with primary pulmonary choriocarcinoma: a case report

Hirokazu Iso, Kakeru Hisakane, Naoki Terashi, Erika Mikami, Satoru Matsuki, Takumi Sonokawa, Kenichiro Atsumi, Naoyuki Yoshino, Kohji Nagata, Masahiro Seike …

TRANSLATIONAL CANCER RESEARCH 2023年7月査読有り

Platinum-combination chemotherapy with or without immune-checkpoint inhibitor in patients with postoperative recurrent non-small cell lung cancer previously treated with adjuvant platinum-doublet chemotherapy: A multicenter retrospective study.

Kakeru Hisakane, Takehiro Tozuka, Satoshi Takahashi, Namiko Taniuchi, Nobuhiko Nishijima, Kenichiro Atsumi, Tetsuya Okano, Masahiro Seike, Takashi Hirose

Thoracic cancer 14(21) 2069-2076 2023年7月査読有り

Lower optimal dose of amrubicin for relapsed small-cell lung cancer: a retrospective study.

Shinji Nakamichi, Kaoru Kubota, Fenfei Zou, Anna Hayashi, Natsuki Takano, Naomi Onda, Masaru Matsumoto, Akihiko Miyanaga, Rintaro Noro, Masahiro Seike

International journal of clinical oncology 28(7) 872-879 2023年7月査読有り

Integrative Analysis of Ferroptosis-Related Genes in Small Cell Lung Cancer for the Identification of Biomarkers and Therapeutic Targets.

Yang Yunchu, Akihiko Miyanaga, Masahiro Seike

Frontiers in bioscience (Landmark edition) 28(6) 125-125 2023年6月28日査読有り責任著者

Soluble interleukin-2 receptor as a predictive biomarker for poor efficacy of combination treatment with anti-PD-1/PD-L1 antibodies and chemotherapy in non-small cell lung cancer patients.

Takehiro Tozuka, Noriko Yanagitani, Hiroshi Yoshida, Ryo Manabe, Shinsuke Ogusu, Ryosuke Tsugitomi, Hiroaki Sakamoto, Yoshiaki Amino, Ryo Ariyasu, Ken Uchibori …

Investigational new drugs 41(3) 411-420 2023年6月査読有り

A Phase I/II Study of Necitumumab Plus Pembrolizumab, Nab-Paclitaxel, and Carboplatin for Previously Untreated Advanced Squamous Non-Small Cell Lung Cancer Study: (NEJ048A/NEXUS).

Akihiko Miyanaga, Hajime Asahina, Satoshi Watanabe, Takehito Shukuya, Yukari Tsubata, Yukio Hosomi, Shunichi Sugawara, Makoto Maemondo, Tetsuya Okano, Satoshi Morita …

Clinical lung cancer 24(4) 371-375 2023年6月

Phase 2 study of osimertinib in combination with platinum and pemetrexed in patients with previously untreated EGFR-mutated advanced non-squamous non-small cell lung cancer: The OPAL Study.

Ryota Saito, Shunichi Sugawara, Ryo Ko, Koichi Azuma, Ryo Morita, Makoto Maemondo, Satoshi Oizumi, Kazuhisa Takahashi, Hiroshi Kagamu, Yukari Tsubata …

European journal of cancer (Oxford, England : 1990) 185 83-93 2023年5月査読有り

70歳以上の非扁平上皮癌患者における複合免疫療法についての検討

戸塚猛大, 野呂林太郎, 中道真仁, 武内進, 松本優, 宮永晃彦, 笠原寿郎, 清家正博

日本呼吸器学会誌 12(増刊) 277-277 2023年3月

清家正博

論文

メニュー

共著者の一覧